Loading…
Type I IFN regulate DC turnover in vivo
DC are the most potent antigen-presenting cells that recognise signs of infection and serve as the main activators of naïve T cells. We have previously shown that type I IFN (IFN-I) are produced by DC and can act in an autocrine manner to activate DC. In the present study, we have investigated the r...
Saved in:
Published in: | European journal of immunology 2009-07, Vol.39 (7), p.1807-1818 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5013-f1d5ec3f303b024e59226a833b821b92f4af5413358f1d52f86ef1efe012b95e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c5013-f1d5ec3f303b024e59226a833b821b92f4af5413358f1d52f86ef1efe012b95e3 |
container_end_page | 1818 |
container_issue | 7 |
container_start_page | 1807 |
container_title | European journal of immunology |
container_volume | 39 |
creator | Mattei, Fabrizio Bracci, Laura Tough, David F Belardelli, Filippo Schiavoni, Giovanna |
description | DC are the most potent antigen-presenting cells that recognise signs of infection and serve as the main activators of naïve T cells. We have previously shown that type I IFN (IFN-I) are produced by DC and can act in an autocrine manner to activate DC. In the present study, we have investigated the role of IFN-I in regulating the turnover and lifespan of DC. We found that DC, especially the CD8α⁺ subset, from type I IFN receptor knock out (IFNAR KO) mice, display a reduced turnover rate when compared with DC from WT mice, as revealed by BrdU labelling kinetics. In vitro, IFNAR KO BM precursor cells cultured in the presence of GM-CSF generated CD11c⁺ DC less efficiently than WT BM, and the IFNAR KO DC that arose displayed reduced migratory ability. Interestingly, splenic DC from IFNAR KO mice exhibited a higher survival rate in short-term culture compared with control DC. Exposure to IFN-I in vivo markedly increased the turnover rate of splenic DC, particularly CD8α⁺ DC, which was preceded by a transient induction of apoptosis. In accordance with this, IFN-I stimulated the apoptosis of splenic DC in vitro. Overall, our data indicate that IFN-I are important regulators of DC turnover in vivo and suggest that these cytokines may exert this function through the modulation of multiple processes involving DC apoptosis, proliferation and migration. |
doi_str_mv | 10.1002/eji.200939233 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67480916</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67480916</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5013-f1d5ec3f303b024e59226a833b821b92f4af5413358f1d52f86ef1efe012b95e3</originalsourceid><addsrcrecordid>eNp90L9PwkAYxvGL0Qiio6t2Upfi-94veqNBUAzRQZgvLbxHSgrFO4rhv7cEok4kl9zyeZ_hy9g1QhsB-CPN8zYHMMJwIU5YExXHWKLEU9YEQBlzk0CDXYQwh5ppZc5ZA42SUiBvsvvRdkXRIBr03yNPs6pI1xQ9d6N15ZflhnyUL6NNvikv2ZlLi0BXh7_Fxv3eqPsaDz9eBt2nYTxRgCJ2OFU0EU6AyIBLUoZznSZCZAnHzHAnU6ckCqGSHeUu0eSQHAHyzCgSLXa331358quisLaLPEyoKNIllVWwuiMTMKhr-HAUotSJ0FpDUtN4Tye-DMGTsyufL1K_tQh2F9HWEe1vxNrfHKarbEHTP32oVoPOHnznBW2Pr9ne2-D_9O3-0qWlTWc-D3b8yetygFppUb8fvzCCnA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1468366608</pqid></control><display><type>article</type><title>Type I IFN regulate DC turnover in vivo</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Mattei, Fabrizio ; Bracci, Laura ; Tough, David F ; Belardelli, Filippo ; Schiavoni, Giovanna</creator><creatorcontrib>Mattei, Fabrizio ; Bracci, Laura ; Tough, David F ; Belardelli, Filippo ; Schiavoni, Giovanna</creatorcontrib><description>DC are the most potent antigen-presenting cells that recognise signs of infection and serve as the main activators of naïve T cells. We have previously shown that type I IFN (IFN-I) are produced by DC and can act in an autocrine manner to activate DC. In the present study, we have investigated the role of IFN-I in regulating the turnover and lifespan of DC. We found that DC, especially the CD8α⁺ subset, from type I IFN receptor knock out (IFNAR KO) mice, display a reduced turnover rate when compared with DC from WT mice, as revealed by BrdU labelling kinetics. In vitro, IFNAR KO BM precursor cells cultured in the presence of GM-CSF generated CD11c⁺ DC less efficiently than WT BM, and the IFNAR KO DC that arose displayed reduced migratory ability. Interestingly, splenic DC from IFNAR KO mice exhibited a higher survival rate in short-term culture compared with control DC. Exposure to IFN-I in vivo markedly increased the turnover rate of splenic DC, particularly CD8α⁺ DC, which was preceded by a transient induction of apoptosis. In accordance with this, IFN-I stimulated the apoptosis of splenic DC in vitro. Overall, our data indicate that IFN-I are important regulators of DC turnover in vivo and suggest that these cytokines may exert this function through the modulation of multiple processes involving DC apoptosis, proliferation and migration.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/eji.200939233</identifier><identifier>PMID: 19544312</identifier><language>eng</language><publisher>Weinheim: Wiley-VCH Verlag</publisher><subject>Animals ; Apoptosis ; Apoptosis - drug effects ; bcl-X Protein - genetics ; Blotting, Western ; Bone Marrow Cells - cytology ; Bone Marrow Cells - drug effects ; Bone Marrow Cells - metabolism ; CD11c Antigen - metabolism ; CD8 Antigens - metabolism ; Cell Movement - drug effects ; Cell Proliferation - drug effects ; Cells, Cultured ; Dendritic Cells - cytology ; Dendritic Cells - drug effects ; Dendritic Cells - metabolism ; Female ; Flow Cytometry ; Gene Expression Regulation - drug effects ; Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology ; Interferon Type I - administration & dosage ; Interferon Type I - metabolism ; Interferon Type I - pharmacology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Inbred Strains ; Mice, Knockout ; Proto-Oncogene Proteins c-bcl-2 - genetics ; Receptors, Interferon - genetics ; Receptors, Interferon - physiology ; Reverse Transcriptase Polymerase Chain Reaction ; Spleen - cytology ; Turnover ; Type I IFN</subject><ispartof>European journal of immunology, 2009-07, Vol.39 (7), p.1807-1818</ispartof><rights>Copyright © 2009 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5013-f1d5ec3f303b024e59226a833b821b92f4af5413358f1d52f86ef1efe012b95e3</citedby><cites>FETCH-LOGICAL-c5013-f1d5ec3f303b024e59226a833b821b92f4af5413358f1d52f86ef1efe012b95e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19544312$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mattei, Fabrizio</creatorcontrib><creatorcontrib>Bracci, Laura</creatorcontrib><creatorcontrib>Tough, David F</creatorcontrib><creatorcontrib>Belardelli, Filippo</creatorcontrib><creatorcontrib>Schiavoni, Giovanna</creatorcontrib><title>Type I IFN regulate DC turnover in vivo</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>DC are the most potent antigen-presenting cells that recognise signs of infection and serve as the main activators of naïve T cells. We have previously shown that type I IFN (IFN-I) are produced by DC and can act in an autocrine manner to activate DC. In the present study, we have investigated the role of IFN-I in regulating the turnover and lifespan of DC. We found that DC, especially the CD8α⁺ subset, from type I IFN receptor knock out (IFNAR KO) mice, display a reduced turnover rate when compared with DC from WT mice, as revealed by BrdU labelling kinetics. In vitro, IFNAR KO BM precursor cells cultured in the presence of GM-CSF generated CD11c⁺ DC less efficiently than WT BM, and the IFNAR KO DC that arose displayed reduced migratory ability. Interestingly, splenic DC from IFNAR KO mice exhibited a higher survival rate in short-term culture compared with control DC. Exposure to IFN-I in vivo markedly increased the turnover rate of splenic DC, particularly CD8α⁺ DC, which was preceded by a transient induction of apoptosis. In accordance with this, IFN-I stimulated the apoptosis of splenic DC in vitro. Overall, our data indicate that IFN-I are important regulators of DC turnover in vivo and suggest that these cytokines may exert this function through the modulation of multiple processes involving DC apoptosis, proliferation and migration.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>bcl-X Protein - genetics</subject><subject>Blotting, Western</subject><subject>Bone Marrow Cells - cytology</subject><subject>Bone Marrow Cells - drug effects</subject><subject>Bone Marrow Cells - metabolism</subject><subject>CD11c Antigen - metabolism</subject><subject>CD8 Antigens - metabolism</subject><subject>Cell Movement - drug effects</subject><subject>Cell Proliferation - drug effects</subject><subject>Cells, Cultured</subject><subject>Dendritic Cells - cytology</subject><subject>Dendritic Cells - drug effects</subject><subject>Dendritic Cells - metabolism</subject><subject>Female</subject><subject>Flow Cytometry</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology</subject><subject>Interferon Type I - administration & dosage</subject><subject>Interferon Type I - metabolism</subject><subject>Interferon Type I - pharmacology</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Inbred Strains</subject><subject>Mice, Knockout</subject><subject>Proto-Oncogene Proteins c-bcl-2 - genetics</subject><subject>Receptors, Interferon - genetics</subject><subject>Receptors, Interferon - physiology</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Spleen - cytology</subject><subject>Turnover</subject><subject>Type I IFN</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp90L9PwkAYxvGL0Qiio6t2Upfi-94veqNBUAzRQZgvLbxHSgrFO4rhv7cEok4kl9zyeZ_hy9g1QhsB-CPN8zYHMMJwIU5YExXHWKLEU9YEQBlzk0CDXYQwh5ppZc5ZA42SUiBvsvvRdkXRIBr03yNPs6pI1xQ9d6N15ZflhnyUL6NNvikv2ZlLi0BXh7_Fxv3eqPsaDz9eBt2nYTxRgCJ2OFU0EU6AyIBLUoZznSZCZAnHzHAnU6ckCqGSHeUu0eSQHAHyzCgSLXa331358quisLaLPEyoKNIllVWwuiMTMKhr-HAUotSJ0FpDUtN4Tye-DMGTsyufL1K_tQh2F9HWEe1vxNrfHKarbEHTP32oVoPOHnznBW2Pr9ne2-D_9O3-0qWlTWc-D3b8yetygFppUb8fvzCCnA</recordid><startdate>200907</startdate><enddate>200907</enddate><creator>Mattei, Fabrizio</creator><creator>Bracci, Laura</creator><creator>Tough, David F</creator><creator>Belardelli, Filippo</creator><creator>Schiavoni, Giovanna</creator><general>Wiley-VCH Verlag</general><general>WILEY‐VCH Verlag</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200907</creationdate><title>Type I IFN regulate DC turnover in vivo</title><author>Mattei, Fabrizio ; Bracci, Laura ; Tough, David F ; Belardelli, Filippo ; Schiavoni, Giovanna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5013-f1d5ec3f303b024e59226a833b821b92f4af5413358f1d52f86ef1efe012b95e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>bcl-X Protein - genetics</topic><topic>Blotting, Western</topic><topic>Bone Marrow Cells - cytology</topic><topic>Bone Marrow Cells - drug effects</topic><topic>Bone Marrow Cells - metabolism</topic><topic>CD11c Antigen - metabolism</topic><topic>CD8 Antigens - metabolism</topic><topic>Cell Movement - drug effects</topic><topic>Cell Proliferation - drug effects</topic><topic>Cells, Cultured</topic><topic>Dendritic Cells - cytology</topic><topic>Dendritic Cells - drug effects</topic><topic>Dendritic Cells - metabolism</topic><topic>Female</topic><topic>Flow Cytometry</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology</topic><topic>Interferon Type I - administration & dosage</topic><topic>Interferon Type I - metabolism</topic><topic>Interferon Type I - pharmacology</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Inbred Strains</topic><topic>Mice, Knockout</topic><topic>Proto-Oncogene Proteins c-bcl-2 - genetics</topic><topic>Receptors, Interferon - genetics</topic><topic>Receptors, Interferon - physiology</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Spleen - cytology</topic><topic>Turnover</topic><topic>Type I IFN</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mattei, Fabrizio</creatorcontrib><creatorcontrib>Bracci, Laura</creatorcontrib><creatorcontrib>Tough, David F</creatorcontrib><creatorcontrib>Belardelli, Filippo</creatorcontrib><creatorcontrib>Schiavoni, Giovanna</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mattei, Fabrizio</au><au>Bracci, Laura</au><au>Tough, David F</au><au>Belardelli, Filippo</au><au>Schiavoni, Giovanna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Type I IFN regulate DC turnover in vivo</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>2009-07</date><risdate>2009</risdate><volume>39</volume><issue>7</issue><spage>1807</spage><epage>1818</epage><pages>1807-1818</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><abstract>DC are the most potent antigen-presenting cells that recognise signs of infection and serve as the main activators of naïve T cells. We have previously shown that type I IFN (IFN-I) are produced by DC and can act in an autocrine manner to activate DC. In the present study, we have investigated the role of IFN-I in regulating the turnover and lifespan of DC. We found that DC, especially the CD8α⁺ subset, from type I IFN receptor knock out (IFNAR KO) mice, display a reduced turnover rate when compared with DC from WT mice, as revealed by BrdU labelling kinetics. In vitro, IFNAR KO BM precursor cells cultured in the presence of GM-CSF generated CD11c⁺ DC less efficiently than WT BM, and the IFNAR KO DC that arose displayed reduced migratory ability. Interestingly, splenic DC from IFNAR KO mice exhibited a higher survival rate in short-term culture compared with control DC. Exposure to IFN-I in vivo markedly increased the turnover rate of splenic DC, particularly CD8α⁺ DC, which was preceded by a transient induction of apoptosis. In accordance with this, IFN-I stimulated the apoptosis of splenic DC in vitro. Overall, our data indicate that IFN-I are important regulators of DC turnover in vivo and suggest that these cytokines may exert this function through the modulation of multiple processes involving DC apoptosis, proliferation and migration.</abstract><cop>Weinheim</cop><pub>Wiley-VCH Verlag</pub><pmid>19544312</pmid><doi>10.1002/eji.200939233</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2980 |
ispartof | European journal of immunology, 2009-07, Vol.39 (7), p.1807-1818 |
issn | 0014-2980 1521-4141 |
language | eng |
recordid | cdi_proquest_miscellaneous_67480916 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Animals Apoptosis Apoptosis - drug effects bcl-X Protein - genetics Blotting, Western Bone Marrow Cells - cytology Bone Marrow Cells - drug effects Bone Marrow Cells - metabolism CD11c Antigen - metabolism CD8 Antigens - metabolism Cell Movement - drug effects Cell Proliferation - drug effects Cells, Cultured Dendritic Cells - cytology Dendritic Cells - drug effects Dendritic Cells - metabolism Female Flow Cytometry Gene Expression Regulation - drug effects Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology Interferon Type I - administration & dosage Interferon Type I - metabolism Interferon Type I - pharmacology Male Mice Mice, Inbred C57BL Mice, Inbred Strains Mice, Knockout Proto-Oncogene Proteins c-bcl-2 - genetics Receptors, Interferon - genetics Receptors, Interferon - physiology Reverse Transcriptase Polymerase Chain Reaction Spleen - cytology Turnover Type I IFN |
title | Type I IFN regulate DC turnover in vivo |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T18%3A15%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Type%20I%20IFN%20regulate%20DC%20turnover%20in%20vivo&rft.jtitle=European%20journal%20of%20immunology&rft.au=Mattei,%20Fabrizio&rft.date=2009-07&rft.volume=39&rft.issue=7&rft.spage=1807&rft.epage=1818&rft.pages=1807-1818&rft.issn=0014-2980&rft.eissn=1521-4141&rft_id=info:doi/10.1002/eji.200939233&rft_dat=%3Cproquest_cross%3E67480916%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5013-f1d5ec3f303b024e59226a833b821b92f4af5413358f1d52f86ef1efe012b95e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1468366608&rft_id=info:pmid/19544312&rfr_iscdi=true |